“Winning War on Cervical Cancer”

Return to Vaccination News Home Page __» Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

——————————————————————————————

Eduardo Franco, director of the cancer epidemiology unit at McGill University, believes that a viable vaccine could be in the works that prevents human papillomavirus (HPV), a common sexually transmitted disease

(STD) that often leads to cervical cancer in women. Franco is leading a study of 12,000 women in Montreal and Newfoundland, Canada, that aims to prove a new screening method is a better predictor of HPV than the annual Pap smears that are the current standard. At the same time, researchers are moving ahead with a vaccine against HPV that could reach the market in just five years and could be administered to children between the ages of nine years and 12 years to ward off the illness.

Return to Vaccination News Home Page __» Right-click to "open in new window"

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.